SYED KAMRAN: Open Payments
NPI 1144842113 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,111 in 34 payments from 17 companies in 2025. Trend: 2023 $526 · 2024 $1,173 · 2025 $1,111
Food & beverage: $1,015Education: $96
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 8 | $246 |
| Caris MPI, Inc. | 1 | $161 |
| Penumbra, Inc. | 1 | $120 |
| Merck Sharp & Dohme LLC | 3 | $86 |
| Geron Corporation | 3 | $74 |
| Exelixis Inc. | 3 | $70 |
| Syndax Pharmaceuticals, Inc. | 3 | $66 |
| Karyopharm Therapeutics Inc. | 2 | $48 |
| Astellas Pharma US Inc | 2 | $34 |
| Genmab U.S., Inc. | 1 | $33 |
Products named: MI CANCER SEEK, Indigo System, JAKAFI, RYTELO, MONJUVI, CABOMETYX, KEYTRUDA, XPOVIO.
Industry payments across TX — which companies pay providers there.
